Magnetic Ventures

Founded in 2018, Magnetic Ventures backs visionary founders using deep technology to transform life sciences. The firm invests at the intersection of technology and life sciences, focusing on opportunities including software tools, artificial intelligence, machine learning, multi-omics, drug discovery, precision medicine, and technology-enabled services. Magnetic Ventures typically enters at seed or Series A and states that its initial checks range from $1 million to $6 million, with reserves for follow-on investments.

The firm supports companies from early formation through later stages, combining capital with hands-on guidance in company building, healthcare regulation, business development, and commercialization. Its team describes expertise spanning engineering, biology, genomics, and biotechnology, and reports decades of experience across industry, academia, and board and advisory roles. Magnetic Ventures invests primarily in North America and Europe, with offices in Boston, Miami, and Research Triangle Park. Its portfolio includes companies applying AI and machine learning to drug discovery, regulatory filings, clinical research, and other healthcare challenges.